BIOLINE RX LIMITED
Q3 2026 13F Holders
Symbol
BLRX
CUSIP
09071M304
Type
Equity
Class
SPONSORED ADR
Num filings
3
Total reported value, excl. options
$617.00
Compare 2026 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type